[Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases]
- PMID: 15573772
[Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases]
Abstract
Objective: The aim of this study involving general pathologists was to assess interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases.
Methods: Ten general pathologists independently reviewed 43 specimens chosen to represent the spectrum of borderline ductal proliferative breast lesions. All slides were blindly reviewed without given standardized criteria, and were classified as either mild usual hyperplasia, moderate-severe usual hyperplasia, mild atypical hyperplasia, moderate-severe atypical hyperplasia, ductal carcinoma in situ, or ductal carcinoma in situ with invasion. According to the years of training, these 10 general pathologists were divided into the experienced group and the less trained group. Interobserver agreement was statistically analyzed using Kappa statistic. Then, by comparing all the diagnoses of individual pathologist with the consensus opinion confirmed by two breast pathologists in terms of Page standard, we acquired the diagnostic accuracy and ascertained the undue diagnosis.
Results: The ten general pathologists' interobserver reproducibility in the diagnosis of borderline ductal proliferative breast diseases was rather low, especially that in their diagnosis of atypical hyperplasia. The reproducibility and accuracy were slightly higher in the experienced pathologists than in the less trained pathologists. Some pathologists made over-diagnosis or under-diagnosis of the lesions to different degrees. However, when the categories of diagnostic terms were simplified, the interobserver reproducibility increased.
Conclusion: The use of standardized criteria is an important approach to increasing the diagnostic reproducibility and accuracy.
Similar articles
-
Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.Diagn Cytopathol. 2004 Oct;31(4):207-15. doi: 10.1002/dc.20098. Diagn Cytopathol. 2004. PMID: 15452908
-
Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.Histopathology. 2008 May;52(6):689-97. doi: 10.1111/j.1365-2559.2008.03016.x. Epub 2008 Apr 5. Histopathology. 2008. PMID: 18397281
-
[Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].Pathologica. 2002 Dec;94(6):299-305. doi: 10.1007/s102420200053. Pathologica. 2002. PMID: 12540993 Italian.
-
Borderline breast lesions: diagnostic challenges and clinical implications.Adv Anat Pathol. 2011 May;18(3):190-8. doi: 10.1097/PAP.0b013e31821698cc. Adv Anat Pathol. 2011. PMID: 21490436 Review.
-
Breast pathology practice: most common problems in a consultation service.Histopathology. 2005 Nov;47(5):445-57. doi: 10.1111/j.1365-2559.2005.02246.x. Histopathology. 2005. PMID: 16241992 Review.
Cited by
-
Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs.Histochem Cell Biol. 2008 Sep;130(3):447-63. doi: 10.1007/s00418-008-0480-1. Epub 2008 Aug 5. Histochem Cell Biol. 2008. PMID: 18679705 Review.
-
Benign proliferative breast diseases among female patients at a sub-Saharan Africa tertiary hospital: a cross sectional study.BMC Surg. 2013 Apr 1;13:9. doi: 10.1186/1471-2482-13-9. BMC Surg. 2013. PMID: 23548039 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical